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ABSTRACT: The use of sludge (biosolids) in land
application may contribute to the spread of organic micro-
pollutants as wastewater treatments do not completely remove
these compounds. Therefore, the development of alternative
strategies for sludge treatment is a matter of recent concern.
The elimination of pharmaceuticals at pre-existent concen-
trations from sewage sludge was assessed, for the ﬁrst time, in
nonsterile biopiles by means of fungal bioaugmentation with
Trametes versicolor (BTV-systems) and compared with the
eﬀect of autochthonous microbiota (NB-systems). The
competition between the autochthonous fungal/bacterial
communities and T. versicolor was studied using denaturing
gradient gel electrophoresis (DGGE) and the cloning/
sequencing approach. An inhibitory eﬀect exerted by T.
versicolor over bacterial populations was suggested. However,
after 21 days, T. versicolor was no longer the main taxon in the
fungal communities. The elimination proﬁles revealed an enhanced removal of atorvastatin-diclofenac-hydrochlorothiazide
(during the whole treatment) and ranitidine-fenoﬁbrate (at short periods) in the BTV biopiles in respect to NB biopiles,
coincident with the presence of the fungus. For ibuprofen-clarithromycin-furosemide, the elimination proﬁles were similar
irrespective of the system, and with carbamazepine no signiﬁcant degradation was obtained. The results suggest that a fungal
treatment with T. versicolor could be a promising process for the remediation of some pharmaceuticals in complex matrices such
as biosolids.
■ INTRODUCTION
Pharmaceuticals comprise a diverse group of therapeutic
compounds intended to improve health. The expanding
world population, discovery of new drugs, and the use of
cheaper generic agents are some of the reasons of the increasing
use of pharmaceuticals.1 After human or veterinary con-
sumption, pharmaceuticals reach urban aquatic environments,
ending up in the wastewater treatment plants (WWTPs), which
are usually regarded as the main points of discharge of
pharmaceuticals into ecosystems.2 The recent concern on the
occurrence and fate of pharmaceuticals in WWTPs and
receiving surface waters and its subsequent monitoring have
revealed the incapability of conventional wastewater treatments
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to completely remove and thus prevent the entrance of these
emerging pollutants into the environment.3,4 Although a
fraction of the pharmaceuticals is removed from the aqueous
phase of wastewater, important amounts remain adsorbed in
the solid sludge, which for some compounds represents the
main removal route during wastewater treatment.5 The sewage
sludge constitutes a ﬁnal residue in the WWTPs. The
application of sludge (biosolids) in agriculture as soil
amendment or in landﬁlls is one of the most applied solutions
for their disposal.6,7 However, legislation on biosolids only
focuses on heavy metals and bacterial pathogens and more
recently in some organic pollutants such as polychlorinated
biphenyls, polycyclic aromatic hydrocarbons, dioxins, and
halogenated compounds,8 without considering pharmaceuticals
and other groups of micropollutants. Therefore, biosolids
become another important input of pharmaceuticals to the
environment,9 as their application results not only in the direct
spread of the therapeutic drugs on soils but eventually in
surface- and groundwater after runoﬀ by rain.10
Nowadays, although the potential impact of pharmaceuticals
in the environment is little understood, studies have emerged
showing their potential deleterious impact on wildlife and
possible eﬀects on ecosystems, including acute and chronic
toxicity, inhibition of natural microbial processes, and spread of
resistance to antibiotics, among others.3,11−14 Moreover, the
potential risk of toxicity due to mixtures, as those found in
sludge, has gained more attention.3
In this context, the search of alternative approaches,
especially eco-friendly treatments for the elimination of organic
pollutants from sludge, is a matter of great interest.
Bioremediation has appeared as an advantageous cleanup
technique of xenobiotics from the environment, and bio-
augmentation, the addition of pregrown microorganisms to
enhance the degradation of unwanted compounds, is a
promising approach of bioremediation.15 White-rot fungi
(WRF) comprise a group of extensively studied organisms
capable to degrade a wide range of pollutants by means of their
extracellular ligninolytic enzymes and intracellular enzymatic
complexes. The degrading versatility of WRF has been reviewed
elsewhere16−18 and includes the transformation of pharmaceut-
icals in deﬁned liquid media,19,20 however their use in
bioaugmentation processes has been reduced due to their
limited colonization potential.21 Most of the research on
degradation by WRF has been performed in deﬁned media or
sterile matrices and bioaugmentation in solid phase is
circumscribed to few reports in soil for the elimination of
PAHs22−25 or pentachlorophenol.26−28 Moreover, bioaugmen-
tation of sewage sludge with single microorganisms has only
been tested with bacteria29 and, as far as the authors know,
never for the treatment of emerging pollutants.
In previous works, we demonstrated the proper colonization
of sewage sludge by the WRF Trametes versicolor and its ability
to remove pharmaceuticals (both spiked and pre-existent) from
this complex matrix in sterile conditions.30,31 The present work
focuses in the next step, which deals with the challenge of
applying the fungus in nonsterile sludge, where the indigenous
microbiota may counteract the fungal growth and its degrading
ability.
This article describes a bioremediation process that employs
T. versicolor as a bioaugmentation agent for the removal of pre-
existent pharmaceuticals from sewage sludge. The dynamics of
the fungal and bacterial communities during the process was
also monitored to understand how indigenous microbiota is
aﬀected by the inoculation of an external fungus.
■ MATERIALS AND METHODS
Pharmaceutical Standards. All of the pharmaceutical and
the corresponding isotopically labeled standards were of high
purity grade (>90%). Detailed information on the providers of
the analytical standards can be found in S1 Chemicals of the
Supporting Information. The individual standard solutions as
well as isotopically labeled standard solutions were prepared
according to Gros et al.32 The solvents, HPLC grade methanol,
acetonitrile, water (Lichrosolv), and formic acid (98%) were
provided by Merck (Darmstadt, Germany).
Sewage Sludge and Bulking Material. Dry sewage
sludge was obtained from the wastewater treatment plant of El
Prat de Llobregat. The plant is located near Barcelona, Spain,
and has a total treatment capacity of two million equivalent
inhabitants. It is a typical biological activated sludge plant with
sludge anaerobic digestion and thermal drying. Sludge
employed in the experiments was obtained from the ﬁnal
stage of processing, that is, after thermal drying (∼10% water
content). The wheat-straw pellets (WSP, ATEA Praha s.r.o.,
Czech Republic) used both as bulking material and
lignocellulosic substrate for fungal growth in bioaugmentation
experiments were kindly provided by Č. Novotny.́
Solid-Phase Bioremediation Treatments. Two treat-
ments were carried out to evaluate the eﬃciency of
pharmaceuticals degradation in sewage sludge and the dynamics
of microbial communities: (i) nonbioaugmented treatment
(addition of WSP, moisture and regulated temperature; NB)
and (ii) bioaugmentation with the fungus T. versicolor (addition
of pregrown fungus on WSP; BTV). To compare the removal
performance of T. versicolor alone, a sterilized system inoculated
with the fungus was included (CTV).
Microcosm Description. Sludge biopile systems with a
total solid dry weight (DW) of approximately 368 g were
prepared in plastic trays with a 20 × 27 cm surface and a height
of 6 cm. The nonbioaugmented sludge contained 38% WSP as
amendment (w/w, dry basis), which were hydrated (1:2 ratio,
w/v) prior mixing with the sludge. The bioaugmented sludge
contained 38% (w/w, dry basis) T. versicolor inoculum grown
on WSP. The strain T. versicolor ATCC 42530 was acquired
from the American Type Culture Collection. Inocula were
prepared by the addition of a blended mycelium suspension33
to WSP (0.65 mL per gram of dry WSP) and pregrowing for 7
d at 25 °C. WSP were hydrated (1:2 ratio, w/v) prior mycelium
addition. Both conditions were done in triplicate biopiles.
Duplicate sterilized biopiles inoculated with T. versicolor were
prepared with autoclaved sludge (121 °C for 30 min) as
described for bioaugmented sludge. In every case, biopiles were
incubated for up to 42 d at 25 °C, periodically homogenized
and moisturized, and sampled for diﬀerent analyses on times 0,
3, 6, 10, 14, 21, 28, 35, and 42 d; time-points are indicated on
the text as tX, where X corresponds to the day of sampling.
Analytical Procedures. Sample Preparation and Analysis
of Pharmaceuticals. The preparation of the solid samples for
the analysis of selected pharmaceuticals was performed
according to Jelic ́ et al.34 In brief, the samples were freeze-
dried and ground, and extracted using an accelerated solvent
extraction system (ASE) (Dionex ASE 200, Dionex; Sunnyvale,
CA). The concentrated extracts were diluted in HPLC water
(methanol content <5%), and processed by solid phase
extraction using Oasis HLB (200 mg, 6 mL) cartridges
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(Waters, Milford, MA) at neutral pH. Instrumental analysis of
the samples was performed by high performance liquid
chromatography coupled to tandem mass spectrometry
(HPLC-MS/MS). HPLC analysis was performed using
Symbiosis Pico (SP104.002, Spark, Holland), equipped with
an autosampler and connected in series with a 4000 QTRAP
Hybrid Triple Quadrupole - Linear Ion Trap mass
spectrometer equipped with a Turbo Ion Spray source (Applied
Biosystems-Sciex, Foster City, CA, USA). Chromatographic
separation was achieved with a Purospher Star RP-18 end-
capped column (125 mm ×2.0 mm, particle size 5 μm)
preceded by a C18 guard column (4 mm ×4 mm, particle size 5
μm), both supplied by Merck (Darmstadt, Germany). The
concentrations of pharmaceuticals were determined using a
previously developed multiresidual methodology for analysis of
pharmaceuticals.32 The internal standard calibration approach
was used for quantiﬁcation. To determine the recoveries, three
samples of each matrix were spiked with a standard mixture of
target analytes. The recoveries ranged from 42 to 123% (RSD <
15%). The instrumental intraday precision ranged from 2 to
13%, for ﬁve injections of a 50 ng mL−1 standard mixture. The
method quantiﬁcation limits (MQL), calculated as ten times
signal-to-noise, ranged from 0.5 to 7.0 ng g−1 DW, and they are
included for the complete list of analyzed compounds (43
drugs) as seen in Table S1 of the Supporting Information.
Ergosterol quantiﬁcation. Ergosterol was measured in
homogeneously mixed samples of solid-phase cultures.
Extraction and quantiﬁcation were performed as previously
described.30 Ergosterol content was expressed as milligrams per
gram of solid DW.
Laccase Activity. Laccase was extracted from solid samples
according to Rodrıǵuez-Rodrıǵuez et al.30 Activity was
measured using a modiﬁed version of the method for the
determination of manganese peroxidase,35 using 2,6-dimethox-
yphenol (DMP) as the substrate (extinction coeﬃcient: 24 800
M−1cm−1).36 Results were expressed as activity units (U) per
gram of solid DW. One U was deﬁned as the number of
micromoles of DMP oxidized per min.
ND24 Test. A test based on naproxen degradation, previously
deﬁned by Rodrıǵuez-Rodrıǵuez et al.37 was employed to
monitor the degrading ability of T. versicolor throughout the
treatment. The test indicates the percentage of degradation of
spiked naproxen in 24 h by comparing the remaining naproxen
concentrations in active cultures to those in heat-killed controls.
Microbial Community Analysis. Sampling and DNA
Extraction. Homogenized samples were withdrawn from the
biopiles over a period of 42 d and stored at −20 °C. Total
genomic DNA was extracted from approximately 0.4 g samples
using the Fast DNA Spin kit for soil (MP Biomedicals, USA)
according to the manufacturer’s instructions. Extracted DNA
was maintained at −20 °C and used as a template for PCR
ampliﬁcation.
PCR Ampliﬁcation. Bacterial 16S rRNA genes and internal
transcribed spacer (ITS) regions of fungal rRNA genes were
ampliﬁed from total genomic DNA using a Taq polymerase kit
(Invitrogen, Carlsbad, CA, USA). PCR ampliﬁcation was
performed in reaction mixture (50 μL) containing 20 mM
Tris-HCl (pH 8.4), 50 mM KCl, 3 mM MgCl2, 200 μM each of
the four deoxynucleoside triphosphates (dNTP), 1.25 U Taq
polymerase, 200 nM each primer, and 1 μL of properly diluted
template DNA. All primers employed were synthesized by
Invitrogen. Complete bacterial 16S rRNA genes were ampliﬁed
for cloning and sequencing by using the forward primer Bact27-
f (5′-GTT TGA TCC TGG CTC AG-3′) and the universal
reverse primer Uni1492-r (5′-CGG CTA CCT TGT TAC
GAC-3′).38 The thermocycling program was: 95 °C for 2 min;
95 °C for 30 s, 52 °C for 40 s and 72 °C for 90 s (25 cycles),
and 72 °C for 5 min. In the case of fungal ITS regions the
forward primer ITS1F (5′-CTT GGT CAT TTA GAG GAA
GTA A-3′)39 and the reverse primer ITS4 (5′-TCC TCC GCT
TAT TGA TAT GC-3′)40 were employed. The thermocycling
program was as described above but with an annealing
temperature of 55 °C. For DGGE analysis, PCR products
were generated using bacterial 16S rRNA gene primers U968-f
(5′-ACC GCG AAG AAC CTT AC-3′) and L1401-r (5′-CGG
TGT GTA CAA GAC CC-3′)41 for ampliﬁcation of the V6−
V8 bacterial region, and the fungal rRNA primers ITS1F and
ITS2 (5′-GCT GCG TTC TTC ATC GAT GC-3′).40 A 40-
base GC clamp (CGC CCG GGG CGC GCC CCG GGC
GGG GCG GGG GCA CGG GGG G) was attached to the
primers U968-f and ITS1F at the 5′ end. The thermocycling
program was as described above but with 35 cycles, an
annealing temperature of 56 °C for bacterial primers and
elongation time of 1 min for fungal primers. The size and
amount of PCR products was estimated by electrophoresis in
1% agarose gels (w/v) using a DNA marker and ethidium
bromide staining.
DGGE Analysis. DGGE analysis of the PCR products was
performed with a DCode system (Bio-Rad, Hercules, CA,
USA). Gels containing 8% (w/v) polyacrilamide (37.5:1
acrylamide/bis-acrylamide) with a denaturing gradient of 30−
60% for bacteria and 20−60% for fungi were employed. The
100% denaturant corresponded to 7 M urea and 40% (v/v)
formamide. Electrophoresis was performed for 16 h at 85 V in
0.5× TAE buﬀer at 60 °C. Gels were then stained with silver
nitrate and scanned in an Epson Perfection V750 PRO (Epson,
USA).
Cloning and Sequencing. Fragments previously ampliﬁed
by PCR using the primers Bact27-f/Uni1492-r and ITS1F/
ITS4 were puriﬁed by means of the PCR cleanup kit
NucleoSpin Extract II (Macherey-Nagel, Germany). The
fragments were then incorporated into a pGEM-T vector
using the pGEM Easy Vector Systems kit (Promega, Madison,
WI, USA). The vector was employed in the transformation of
Escherichia coli competent cells E. cloni 10G Electrocompetent
Cells (Lucigen Corporation) according to the manufacturer’s
instructions. Positive transformants were selected after growth
in LB medium supplemented with ampicillin. After PCR
ampliﬁcation with U968GC-f/L1401-r or ITS1FGC/ITS2,
clones were screened in DGGE by means of comparing with
the corresponding band-patterns of the sludge. Those clones
matching diﬀerent bands in the total community proﬁle were
selected, and their inserts were ampliﬁed by PCR using the
pGEM-T vector-targeted sequencing primers Sp6 (5′-GAT
TTA GGT GAC ACT ATA G-3′) and T7 (5′-TAA TAC GAC
TCA CTA TAG GG-3′) (Promega), puriﬁed (NucleoSpin
Extract II kit) and subjected to DNA sequence analysis. Inserts
were bidirectionally sequenced with the primers Sp6/T7 at
Euroﬁns MWG Operon (Ebersberg, Germany).
Phylogenetic Analysis. Partial sequences were assembled
using the CAP application included in the BioEdit v7.0.9
software package.42 Similarity searches for the assembled
sequences were performed using the NCBI Blast search
program within the GenBank database (http://www.ncbi.nlm.
nih.gov/blast/).43
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■ RESULTS
Parameters of Growth and Activity in Bioaugmenta-
tion with T. versicolor. Solid-phase biopile systems were
employed to study the bioaugmentation of sewage sludge with
T. versicolor for the removal of pharmaceuticals. The
lignocellulosic WSP employed in the biopiles acted both as a
substrate (C and N source) for fungal growth and a carrier of T.
versicolor. Preliminary studies revealed that the preparation of
the biopiles as described by Rodrıǵuez-Rodrıǵuez et al.31 in
sterile conditions could not support the colonization of the
nonsterile sludge by the fungus (data not shown); therefore, a
reduction in the initial moisture (aprox. from 2.6 to 2.2 g water
per g DW) of the system was applied to favor the colonization
of the matrix in the BTV biopiles. Figure 1 shows the results of
ergosterol, employed as an indicator of fungal biomass,44 and
laccase, as an indicator of extracellular enzymatic activity of T.
versicolor, directly related to the oxidative potential of the
system and involved in the degradation of several polutants.16
BTV and CTV presented similar ergosterol proﬁles (part A of
Figure 1), with maximum values (0.091 mg g−1 DW and 0.092
mg g−1 DW, respectively) in the ﬁrst days of the treatment. The
proﬁle of NB biopiles was more oscillatory, though values were
usually higher than those shown by BTV and CTV biopiles
after 6 d. However, by the end of the process, ergosterol in the
NB biopiles matched the ﬁnal value of the BTV biopiles.
Laccase activity proﬁle of BTV systems revealed high levels in
the ﬁrst 10 d (maximum 4.58 U g−1 DW at day 3), with a
posterior decrease and a new raise between t28 and t35 (part B
of Figure 1). Results were similar, though higher, for the
replicates of the CTV, with peak values of around 7.66 U g−1
DW, but the expression of the enzymatic activity started later in
this case. No activity was detected in the NB biopiles, except at
t35 (0.08 U g−1 DW), at a negligible value compared to the
other systems. The ND24 test, employed as an indicator of
degrading ability of T. versicolor, presented degradation values
over 10% only at t6 in the BTV biopiles (ND24 values are
shown in Table S2 of the Supporting Information).
Removal of Pharmaceuticals from Sludge. From 43
pharmaceuticals analyzed, 9 were detected in the sewage
sludge; their elimination proﬁles are shown in Figure 2. The
most abundant therapeutic agents were the analgesic/anti-
inﬂammatory compounds ibuprofen and diclofenac (Table 1).
Removal of ibuprofen after 42 d was similar in all the
bioremediation treatments, ranging from 55.9% to 61.0%
(Table 1). Contrary, diclofenac was better degraded in the
BTV (54.0%) and CTV (60.5%) biopiles, against only 22.0% in
the NB systems.
Two lipid regulators, fenoﬁbrate and atorvastatin, were
detected. The former was easily removed from the sludge, as it
completely disappeared at the end of the process, with or
without bioaugmentation. However, atorvastatin was more
eﬃciently removed in the BTV (65.4%) and CTV (70.4%)
biopiles, whereas elimination exclusively due to indigenous
microbiota reached 48.4%.
In the cases of the histamine H2-receptor antagonist
ranitidine and the diuretic furosemide, the degradation was
complete in all the systems, by the end of the treatment for the
former, and by t10 for the latter. Similarly, for the antibiotic
clarithromycin the removal was the same irrespective of the
process, between 81.7% and 84.5% after 42 d. The other
diuretic, hydrochlorothiazide, showed a slightly better removal
in the biopiles with T. versicolor (65.4% in BTV and 62.7% in
CTV) than the NB biopiles (55.3%). Finally, carbamazepine,
detected at an initial concentration of 10.5 ng g−1 (±0.7) was
the only drug that remained unchanged regardless of the
applied treatment.
Dynamics and Characterization of Fungal and
Bacterial Communities. DGGE proﬁles were obtained for
samples of the triplicate BTV and NB biopiles. Proﬁles in the
replicates were highly similar for bacterial and fungal
communities, and thus only the results of one of the replicates
are included. A more detailed analysis of the structure of the
microbial communities was also performed by cloning and
sequencing analyses of the 16S rRNA gene and ITS regions of
fungal rRNA gene Figure 3.
DGGE proﬁles of fungal communities are shown in parts A
and B of Figure 3. In the NB biopiles, bands were absent at t0
and only one band weakly appeared at t6; after t10 a higher
fungal diversity was observed, with several bands that were
present up to t42 (part A of Figure 3). Sample TV corresponds
to the product ampliﬁed from the genomic DNA of a pure
culture of T. versicolor. In the BTV biopiles this band prevailed
alone until t10, and shared predominance in the community on
t21; however, it disappeared by the end of the treatment at t42,
when the predominant bands included those also found in the
NB biopiles (part B of Figure 3). Fungal sequences
corresponding to bands F1, F5 and F8 showed high similarity
to Scopulariopsis brevicaulis, a common soil saprophyte.45 These
Figure 1. Proﬁles of ergosterol (A) and laccase activity (B) over time
in the bioremediation treatments of sewage sludge: NB (○), BTV (●),
CTV (□). Values plotted are the means ± standard deviation (SD) for
triplicate biopiles, except for CTV in B (two replicates individually
plotted).
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bands developed with higher relative intensity in the samples
from NB biopiles. Bands F2, F6, and F9, whose sequences
matched with isolates of Gymnascella dankaliensis (99−100%
identity) were predominant in BTV systems. The sequences
corresponding to the bands F3 and F7 were 91% identical to
the sequence of the cephalosporin-producer Acremonium
chrysogenum,46 which appeared by t42 in both systems. At t42
but only in samples from BTV biopiles a band (F4) appeared,
whose sequence has a 99% identity to an isolate of Gymnoascus
sp. Both G. dankaliensis and Gymnoascus sp. are gymnoasca-
ceous keratinophilic fungi usually found in soils.47 An additional
clone not assigned in the DGGEs, with a gene sequence related
to Cephaliophora tropica (98% identity), a soil fungus,48 was
obtained from the sample collected at t21 from the BTV
biopiles. Overall results indicate that, with exception of T.
versicolor, the fungal communities were similar in the NB and
BTV treatments.
The DGGE proﬁles corresponding to the bacterial
communities are presented in parts C and D of Figure 3.
The NB biopiles showed higher diversity (in terms of number
of bands) than the BTV biopiles. Several bands appeared after
t0 and, although weak, some prevailed along the process.
However, in the BTV biopiles the diversity observed at t0
disappeared during the treatment to produce the same pattern
Figure 2. Time-course removal of detected pharmaceuticals in the sludge biopiles during a 42 d bioremediation treatment: NB (●), BTV (○), and
CTV (▼). Values plotted are the means ± SD for triplicate biopiles.
Table 1. Initial Concentration of Pharmaceuticals Detected in the Sewage Sludge and Degradation in Diﬀerent Bioremediation
Strategies
degradation (%, average)
pharmaceutical MQL (ng g−1 DW) recovery (%, n = 3)
initial concentration
(average)
concentration range, t0
(min−max) NB t42 BTV t42 CTV t42
fenoﬁbrate 1.8 55 (±13) 13.7 (±1.8) 12.0−15.6 100 100 100
atorvastatin 2.9 59 (±8.2) 19.3 (±2.6) 16.6−21.8 48 (±10) 65 (±10) 70 (±12)
hydrochlorothiazide 2.6 87 (±14) 10.8 (±1.7) 9.4−12.6 55 (±11) 65 (±11) 63 (±14)
diclofenac 3.6 67 (±7.3) 53.6 (±4.8) 48.4−57.6 22 (±7) 54 (±6) 60 (±8)
clarithromycin 3.1 73 (±3.0) 35.8 (±6.8) 29.1−35.6 85 (±15) 82 (±14) 84 (±17)
ranitidine 5.3 42 (±13) 17.5 (±1.3) 16.1−18.7 100 100 100
carbamazepine 1.0 121 (±11) 10.5 (±0.7) 9.9−11.2 9 (±8)
ibuprofen 2.7 63 (±7.9) 161.0 (±21.4) 138−181 61 (±9) 56 (±9) 60 (±11)
furosemide 3.9 42 (±8.7) 23.4 (±1.7) 22.3−25.3 100 100 100
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up to t42, which consisted of a predominant band that
coexisted with the fungal population. The 16S rRNA gene
sequence corresponding to band B1 showed high identity
(99%) to an isolate of Staphylococcus equorum. This band was
present in the NB biopiles but absent in the presence of T.
versicolor. The two bands present throughout each of the
processes, for example B2 and B3, have sequences that matched
isolates belonging to the family Bacillaceae, Oceanobacillus sp.
(99% identity) and Bacillus sp. (99% identity), which are genera
that normally occur in wastewater treatment systems.49 An
additional clone obtained from the sample collected at t10 from
BTV biopiles, whose sequence was 100% identical to the 16S
rRNA gene sequence of Bacillus cereus, could not be assigned to
a band in the DGGE proﬁles.
■ DISCUSSION
The present work addresses a fungal approach for the
elimination of pharmaceuticals, a group of emerging pollutants,
from thermally dried sewage sludge. The bioaugmentation with
T. versicolor (BTV) was compared with the eﬀect achieved with
solely the indigenous microbiota of the sludge, which given its
proliferation due to the use of WSP (observed in community
analyses), could be considered as a biostimulation process
(NB).
Although ergosterol has been previously applied to monitor
fungal biomass production, results from NB biopiles (usually
higher than BTV and CTV, contrary to what was expected
given the size of the inoculum) suggest that it is not a suitable
parameter to follow up the speciﬁc bioaugmentation with T.
versicolor. This can be ascribed to the fact that ergosterol
production (respect to total fungal biomass) is species-
speciﬁc,44 and growth of indigenous fungi in NB biopiles
with higher ergosterol production yields could surpass the
amount due only to T. versicolor. However, laccase determi-
nation seemed to be a good parameter to monitor activity of T.
versicolor in the bioaugmented systems as its production was
negligible in NB biopiles. Although the laccase produced could
participate in the elimination of some pharmaceuticals in the
BTV biopiles, the pollutant transformation ability of T.
versicolor is a complex process that, besides the extracellular
lignin-modifying enzymes (such as laccase), also involves the
intracellular cytochrome P450 system and probably additional
mechanisms yet to be described.50,51 Similarly, results of the
ND24 test in the BTV biopiles were much lower than those
previously obtained under sterile conditions31,37 making the
Figure 3. DGGE proﬁles of fungal PCR-ampliﬁed ITS fragments and bacterial PCR-ampliﬁed 16S rRNA gene fragments from sludge microcosms
over a period of 42 d. Fungal proﬁles: (A) Non-bioaugmented, NB and (B) bioaugmented, BTV; bacterial proﬁles: (C) non-bioaugmented, NB and
(B) bioaugmented, BTV. TV corresponds to the ampliﬁed product from genomic DNA of a T. versicolor pure culture. Phylogenetic aﬃliation of the
retrieved ITS or 16S rRNA sequences and their corresponding band position in the DGGE proﬁles are shown on the right.
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test of reduced applicability in this case due to the delay or
inhibition in naproxen degradation by the interaction between
T. versicolor and the microbiota.
Fungal DGGE proﬁles of BTV biopiles demonstrated that T.
versicolor was able to survive in the sludge system (at least
during half of the process), that is the fungus was not inhibited
by autochthonous microbiota. Moreover, comparison of DGGE
proﬁles of bacterial communities, on the contrary, revealed an
inhibitory eﬀect of T. versicolor over bacteria, as diversity shown
in NB biopiles was reduced to one predominant band in the
proﬁle of BTV biopiles. This ﬁnding corresponds to a usually
challenging key factor to overcome in bioaugmentation with
fungi, since these microorganisms are commonly surpassed by
bacteria in terms of colonization ability. The success of fungi in
situations of competition with indigenous microbiota widely
diﬀers,23,52,53 in particular with respect to colonization of soil by
T. versicolor.21,54,55 In the present case, the colonization could
have been enhanced by the reduction of microbiota by the
thermal treatment of the sludge in the WWTP and the
application of low humidity conditions together with the use of
the WSP as lignocellulosic substrate that favors the activity of
WRF. The sporulated nature of most of the bacterial taxa
identiﬁed is not strange given the origin of the sludge
(thermally dried), and might correspond to survivors of that
thermal process. Similarly, T. versicolor seemed to delay the
colonization of the system by other fungi, which appeared as
intense bands at t10 and t21 in DGGE proﬁles from NB and
BTV biopiles, respectively. Those fungi can also correspond to
survivors of the stabilization treatment or to recontamination
organisms.
Degradation of all the pharmaceuticals found in this work has
been reported from sterile sludge systems with T. versicolor in
solid phase (except ranitidine and furosemide)31 and in
bioslurry reactors (except fenoﬁbrate and clarithromycin).56
The persistence of carbamazepine (widely known for its
recalcitrance), which remained unchanged after the treatment,
is remarkable under nonsterile conditions, as degradation values
of 31% and 43% were obtained in sterile sludge systems with
this fungus,31,56 which could suggest a counteracting eﬀect of
the indigenous biota on the degrading ability of the fungus
toward this drug. Moreover, the degradation of this therapeutic
drug has been evidenced by T. versicolor in liquid medium.57
Nonetheless, several analytical issues which point the
appearance of a carbamazepine metabolite at the same
retention time as the parent compound (during liquid phase
degradation by T. versicolor) could indicate an underestimation
in the degradation obtained in the biopiles (unpublished
results).
For the removal of some pharmaceuticals no signiﬁcant
diﬀerence was obtained between BTV and NB biopiles, which
indicates that the addition of the WSP may stimulate also the
growth of indigenous microorganisms, as shown in NB-DGGE
proﬁles. Likewise, degrading proﬁles of BTV and CTV systems
are highly similar in most cases, which suggest that microbial
interactions between the sludge microbiota and T. versicolor did
not counteract the degrading ability of the fungus, a common
issue when bioaugmentation agents are employed. In this
respect, cooperation and antagonism phenomena have been
described in microbiota-fungi interactions in pollutant degra-
dation processes.52,53,58
In general, the fungal-mediated treatments (BTV and CTV)
tended to result in higher degradation in shorter periods (by
t10 or t21) than nonbioaugmented systems. Nonetheless, by
the end of the process the NB biopiles equated the degradation
accomplished in the former systems for many pharmaceuticals.
That accelerated removal eﬀect due to the presence of T.
versicolor was coincident with its predominance in the systems
during the ﬁrst half of the treatment as demonstrated in the
DGGE proﬁles. When comparing the removal of pharmaceut-
icals in NB and BTV biopiles, three kinds of proﬁles were
observed: (i) compounds with higher removal in BTV biopiles,
(ii) pharmaceuticals with similar removal regardless of the
process, and (iii) drugs with negligible removal. Group (i)
proﬁles include atorvastatin, diclofenac, and hydrochlorothia-
zole, in which the action of T. versicolor resulted in enhanced
removal values throughout the process. In the case of
fenoﬁbrate and ranitidine an improved removal in the BTV
biopiles was obtained during the ﬁrst 21 d (complete
elimination in the former) coincident with the period in
which T. versicolor is the predominant taxon of the system,
according to the results of the DGGEs of fungal communities,
and more active according to the results from the ND24 test.
However, a complete removal was achieved with both BTV and
NB systems at the end of the process, indicating a slower but
eﬃcient degrading ability by the indigenous microbiota.
Ibuprofen, clarithromycin, and furosemide comprise the
group (ii) degrading proﬁles, in which no clear diﬀerence
between the BTV and NB systems was found. Complete
elimination of furosemide was fast (by t10), whereas in the case
of ibuprofen and clarithromycin a steep elimination occurred in
the ﬁrst 10 d followed by a plateau (∼56−60% and 82−85%,
respectively). These results suggest that the fungal bioaugmen-
tation process is not necessary for the removal of such
pharmaceuticals, yet the presence of the fungus does not
negatively aﬀect the elimination of the drugs. Group (iii)
proﬁles includes only carbamazepine, which in this case was not
signiﬁcantly removed as indicated above. Though this
therapeutic drug has been widely considered as a non-
biodegradable compound in anaerobic digestion processes
and WWTPs,2,59 its depletion has been demonstrated in sterile
conditions with T. vesicolor in liquid phase and sludge.31,56,57
Summarizing, important potential in bioremediation of
sludge was demonstrated by T. versicolor for the elimination
of pharmaceuticals. Molecular and analytical results suggest a
reduction in the activity of T. versicolor after 21 d of treatment.
Therefore, additional strategies such as fungal reinoculation
should be conducted in order to improve a potential
bioremediation process. Likewise, important, although usually
slower removal of pharmaceuticals by autochthonous micro-
biota should be further studied to consider the application of
biostimulation or natural attenuation techniques as it has been
described with partial success for some traditional environ-
mental pollutants. Similarly, the degrading range of the fungus
for the elimination of other emerging as well as traditional
contaminants must be evaluated in these real conditions to
estimate the reach of such process. The proposed treatment
could be interesting from the applicability point of view, as the
use of these composting-like technologies is widely extended in
WWTPs. Nonetheless, a careful optimization of the incipient
process here described should be performed (considering the
search of cheaper lignocellulosic susbstrates and inoculum size
among other aspects) before assessing an economic study to
estimate the balance between the cost and the eﬀects of the
complete degradation spectrum of the fungus in the sludge.
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